Insider transaction reports filed and disclosed on Monday show a mix of targeted purchases and material sell-offs across several sectors. The following provides a company-by-company account of the most prominent disclosures, with transaction dates, share counts, prices and resulting ownership positions where provided.
Top buys
-
First Community Bankshares - Derek A. Bonnett, the company’s Chief Risk Officer, purchased 501 shares on January 30, 2026, at $34.93 per share, for a total reported outlay of $17,499. After that purchase Bonnett directly holds 1,917 shares of the common stock and indirectly holds another 1,331 shares through the Employee Stock Ownership & Savings Plan.
-
Texas Pacific Land Corp - Horizon Kinetics Asset Management LLC reported the acquisition of a single share on January 30, 2026, at $345.57. While the monetary value of this transaction was only $345, the filing notes that Horizon Kinetics’ total ownership in the company stands at 3,487,703 shares following the purchase.
-
Virtus Dividend, Interest & Premium Strategy Fund - Ten percent owner Saba Capital Management, L.P. acquired 88,639 shares over January 29 and 30, 2026, at $13.44 per share. The transactions totaled $1,191,308 and increased Saba Capital’s reported holdings to 9,603,932 shares of the fund.
-
ASA Gold & Precious Metals Ltd - Saba Capital Management, L.P., also a ten percent owner of this issuer, completed two purchases: 17,075 shares at $74.59 per share on January 29, 2026, and an additional 21,708 shares at $65.56 per share on January 30, 2026. The filings note that these buys occurred as the stock experienced an 11.65% decline over the past week from its previous close of $72.03.
-
Elutia INC. - Director Guido J. Neels purchased 20,000 shares of Class A Common Stock on January 30, 2026. The reported purchase prices ranged from $1.03 to $1.07, with a weighted average price of $1.04 per share. The total transaction value was $20,800 and the filing shows Neels’ direct ownership rising to 118,750 shares.
Top sells
-
Ionis Pharmaceuticals - CEO Brett P. Monia sold 62,970 shares on January 30, 2026, for proceeds of approximately $5.2 million. The sale prices were reported in a range from $82.26 to $82.925. The filing notes the company’s shares trade near a 52-week high of $86.15. The disclosure also records that Monia had acquired 122,214 shares on January 29, 2026, from vested performance-based restricted stock units. The company’s stock has risen 158.54% over the past year and the filing lists a current market capitalization of $13.45 billion.
-
SCHWAB CHARLES CORP - Co-Chairman Charles R. Schwab sold 145,650 shares on January 29, 2026, realizing roughly $15 million. The sales were executed at prices ranging from $103.00 to $103.46, with a reported weighted average price of $103.1649. After the sale, the filing indicates that Schwab continues to hold substantial positions through multiple entities, including 30,641,981 shares held by a Limited Partnership and 55,947,329 shares held indirectly by a Trust.
-
Axsome Therapeutics - CEO Herriot Tabuteau sold 32,410 shares on February 2, 2026, receiving approximately $6.0 million. The reported sale prices ranged from $183.85 to $186.89, with a weighted average sale price of $185.60. The same-day filings show Tabuteau exercised options to acquire 32,410 shares at $8.02 per share, a price the filing characterizes as a significant discount to the then-current market price of $185.88.
-
SEI Investments Co - Chief Executive Ryan Hicke sold 79,990 shares on January 29, 2026, for about $6.99 million. The sale prices were reported between $86.75 and $88.06 per share. The disclosure also records that Hicke exercised options to acquire 80,000 shares at prices ranging from $48.47 to $71.12, for a total exercise cost of $4.9 million.
-
PrimeEnergy Resources CORP - Ten percent owner Robert de Rothschild sold 20,151 common shares across transactions on January 29 and 30, 2026, for an aggregate of $3.7 million. The company was reported to be trading at $177.47 with an approximate market capitalization of $289 million. The filings specify the sales were executed in two transactions, including one on January 29 in which 10,151 shares were sold at prices ranging from $183.015 to $187.21.
Why monitor insider activity
Insider purchases and sales give investors another lens on how those closest to a company view its prospects. Buying by executives or major holders is often interpreted as a signal of confidence in future performance, while sizable sales can be read by some market participants as concern about valuation or growth expectations. The disclosures also make clear that insiders sell for many reasons that are not directly linked to their assessment of the business - including personal financial planning, diversification and tax considerations. As the filings and examples above illustrate, insider activity can provide context for investment decisions but should be assessed alongside fundamental analysis and broader market trends.
Note: Filings were disclosed with the dates, prices and share counts indicated above. The article presents the transactions as reported and does not infer motives beyond the descriptions included in the disclosures.